Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Neuroimaging of Babies During Natural Sleep to Assess Typical Development and Cerebral Palsy

A legfontosabb adatok

Ki végzi
Danish Research Centre for Magnetic Resonance
Hol
Dánia1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
200 fő, tervezett
Kezdés
2024. jún. 1.
Várható befejezés
2027. dec. 31.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • No intervention, observational
A regiszteradat frissítve
2026. január 28.

Ki vehet részt

The trial is looking for babies at high risk of cerebral palsy, and typically developing babies. Babies get brain MRI scans during natural sleep and tests of movement and thinking.

Életkor
2 Months to 11 Months
Nem
All
A betegség stádiuma
High-risk group: for example birth before 32 weeks, birth weight below 1500 g, moderate to severe brain injury, or signs such as not sitting alone by 9 months or uneven hand use. Typical group: born after 37 weeks, uneventful birth, no brain injury or neurological condition.
A részvétel fő kizáró okai
  • Babies who cannot have an MRI, for example with a pacemaker or other implanted electronic device
  • Families who do not speak or understand Danish
  • Families who do not want to be told about unexpected MRI findings or test scores in the clinical range
A regiszter összes feltétele (18)A regiszter feltételeinek elrejtése

Ki vehet részt

  • Group: 'Newborn-detectable risk-pathway'
  • Preterm birth with gestational age below 32 weeks
  • Birth weight below 1500 g
  • Moderate to severe brain injury (A label of moderate to severe brain injury was considered if there was Papile grade three to four intraventricular haemorrhage, cystic periventricular leukomalacia, neonatal stroke, term hypoxic-ischaemic encephalopathy (≥35 weeks gestation at birth) or other significant neurological condition)
  • History (e.g., neonatal seizures, ECMO, meningitis, kernicterus, severe hypoglycemia) or neurological risk factors (malformations in CNS, increased tone); Group: 'Infant detectable risk-pathway'
  • Inability to sit independently by age 9 months
  • Hand function asymmetry or crawl asymmetry
  • Inability to take weight through the plantar surface of the feet
  • History (e.g., as above) or neurological risk factors; Additional inclusion criteria for inclusion in NIBS-CP for both CP-risk groups:
  • Consent to health-relevant information on clinical findings being passed on to the medical doctors in CP-EDIT and/or their primary care physician
  • Born >37 weeks
  • Uneventful birth
  • No known history of brain injury
  • No neurological condition
  • Consent to health-relevant information on clinical findings being passed on to their primary care physician or relevant medical doctors, e.g., neuropaediatrician

Ki nem vehet részt

  • Infants have any MRI contraindications, e.g., pacemaker or other implanted electronic devices
  • Families do not speak or understand Danish
  • Families do not wish to be informed about incidental findings on the MRI, or scores within the clinical range in the neurological, motor, or cognitive assessments

Alkalmassági kérdőív

Ez nem döntés: hogy ki vehet részt, azt csak a vizsgálat csapata mondhatja meg.

  • Cerebral palsy vagy infant development

Ez a vizsgálat jelenleg itt érhető el: Dánia.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Background: Early diagnosis of cerebral palsy (CP) is crucial, enabling intervention when neuroplasticity is at its highest. Magnetic resonance imaging (MRI) plays a vital role in CP diagnosis. Currently, diagnostic MRI of newborns and infants with suspected brain damage relies heavily on structural MR images. The current study aims to i) establish procedures for clinical infant and toddler MRI during natural sleep, ii) use advanced MRI sequences, such as advanced diffusion-weighted imaging (DWI), that may be more sensitive in detecting early brain damage, and iii) map relationships between early brain development, and motor function and development.

A teljes eredeti leírásKevesebb

Methods: The NIBS-CP study will enroll approximately 200 infants either at risk for CP or typically developing. Infants will be followed longitudinally (for three waves) between 3 months and 2 years of age with cerebral MRI at 3 Tesla and comprehensive assessments of motor and cognitive functioning. The MRI protocol includes advanced diffusion-weighted imaging, high-resolution structural MRI, and MR spectroscopy. The motor and cognitive assessments include Hand Assessment in Infants, Alberta Infant Motor Scales, Hammersmith Infant Neurological Examination, Peabody Developmental Motor Scales, Bayley Scales of Infant Development, and Ages and Stages Questionnaires. NIBS-CP aims to establish normative material on early brain development of Danish children and conduct normative modeling of typical and atypical development to identify deviations in brain development at the level of the single child.

Discussion: Identifying predictive brain structural features of motor function and motor development is key to the future use of early MRI in the clinical work-up, as this promotes early diagnosis and (clinical) intervention strategies tailored to the individual child.

A vizsgálat 2 csoportja

  • Typically developing infants

    Born after gestational week 37, Uneventful birth, No known history of brain injury, No known neurological disorders

    Kezelés: No intervention, observational

  • High Risk for Cerebral Palsy

    Recruitment through CP-EDIT (Clinical trials.gov ID: NCT05835674), inclusion criteria. 'Newborn-detectable risk-pathway'. Preterm birth with gestational age below 32 or birth weight below 1500 g and clinical concern, Moderate to severe brain injury (Papile grade 3 to 4 intraventricular haemorrhage, cystic periventricular leukomalacia, neonatal stroke, term hypoxic-ischaemic encephalopathy (≥35 weeks gestation at birth) or other significant neurological condition), History (e.g. neonatal seizures, Extra Corporal Membrane Oxygenation, meningitis, kernicterus, severe hypoglycemia) or neurological risk factors (brain malformation, increased tone), Parental concern and one of the factors above 'Infant detectable risk-pathway'. Inability to sit independently by age 9 months, Hand function asymmetry or crawl asymmetry, Inability to take weight through the plantar surface of the feet, History (as above) or neurological risk factors, Parental concern and one of the factors above.

    Kezelés: No intervention, observational

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Kérdések a feltételekről
Forrás: NCT06396520: ki vehet részt
A regiszteradat frissítve
2026. január 28.